Inventor · Burlingame, CA, US

Daniel J. Burdick

16Patents

5h-index

48Co-inventors

62Inventor score

Filing activity: Nov 26, 2001 → May 26, 2020

Most-cited inventions

Patent	Title	Area	Cited by	Status
US6667318B2	LFA-1 antagonist compounds	Chemistry; Metallurgy	34	Expired
US6872735B2	LFA-1 antagonist compounds	Chemistry; Metallurgy	29	Expired
US8815882B2	Pyrazole aminopyrimidine derivatives as LRRK2 modulators	Chemistry; Metallurgy	18	Active
US8354420B2	Aminopyrimidine derivatives as LRRK2 inhibitors	Chemistry; Metallurgy	14	Active
US9212173B2	Pyrazole aminopyrimidine derivatives as LRRK2 modulators	Human Necessities	8	Active
US8802674B2	Aminopyrimidine derivatives as LRRK2 modulators	Chemistry; Metallurgy	5	Active
US8809331B2	Aminopyrimidine derivatives as LRRK2 modulators	Chemistry; Metallurgy	5	Active
US10206931B2	Therapeutic compounds and uses thereof	Chemistry; Metallurgy	3	Active
US10239861B2	Therapeutic compounds and uses thereof	Chemistry; Metallurgy	2	Active
US10150767B2	Therapeutic compounds and uses thereof	Chemistry; Metallurgy	1	Active
US10183009B2	Therapeutic compounds and uses thereof	Emerging Cross-Sectional Technologies	1	Active
US9382257B2	Substituted pyrrolo[2,3-b]pyrazines as serine/threonine kinase inhibitors	Human Necessities	0	Active
US10258603B2	Therapeutic compounds and uses thereof	Chemistry; Metallurgy	0	Active
US10202378B2	Therapeutic compounds and uses thereof	Chemistry; Metallurgy	0	Active
US11034725B2	Compositions and methods for treating cardiovascular disease	Physics	0	Active
US10787484B2	Compositions and methods for treating cardiovascular disease	Physics	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.